Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K-H Franke

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Ultramicroscopy|June 26, 2007
Using defined structures on very thin foils for characterizing AFM tipsT Machleidt, K-H Franke, H Romanus, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2000
DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladderA R Florl, K H Franke, D Niederacher, et al.
The Prostate|November 14, 2000
Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinomaF Kimura, K H Franke, C Steinhoff, et al.
Urology|October 6, 2000
Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinomaK H Franke, M Miklosi, P Goebell, et al.
Archives of Toxicology|December 29, 2000
Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinomaC Steinhoff, K H Franke, K Golka, et al.
Archives of Toxicology|August 26, 2000
Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of associationM Steiner, M Bastian, W A Schulz, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Ultramicroscopy|June 26, 2007
Using defined structures on very thin foils for characterizing AFM tipsT Machleidt, K-H Franke, H Romanus, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|October 25, 2000
DNA methylation and the mechanisms of CDKN2A inactivation in transitional cell carcinoma of the urinary bladderA R Florl, K H Franke, D Niederacher, et al.
The Prostate|November 14, 2000
Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinomaF Kimura, K H Franke, C Steinhoff, et al.
Urology|October 6, 2000
Cyclin-dependent kinase inhibitor P27(KIP1) is expressed preferentially in early stages of urothelial carcinomaK H Franke, M Miklosi, P Goebell, et al.
Archives of Toxicology|December 29, 2000
Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinomaC Steinhoff, K H Franke, K Golka, et al.
Archives of Toxicology|August 26, 2000
Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of associationM Steiner, M Bastian, W A Schulz, et al.
Pageof 1